Reported by Mr. Grassley, with an amendment, Mr. Cornyn (for himself, Mr. Blumenthal, Mr. Grassley, and Mr. Durbin) introduced the following bill; which was read twice and referred to the Committee on the Judiciary
5 U.S.C. 553 15 U.S.C. 12, 41, 45
and
57c-2 21 U.S.C. 355, 355, 355a
and
355c 42 U.S.C. 262
and
262
Document Citations
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Drug Competition Enhancement Act. S. 1040. 119th
Cong., 1st
sess., Reported in Senate April 10, 2025. https://www.govinfo.gov/app/details/BILLS-119s1040rs.
APA
Congress, Senate (2025, April 10). Drug Competition Enhancement Act (S. 1040 (RS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s1040rs.
MLA
United States, Congress, Senate. Drug Competition Enhancement Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s1040rs. 119th Congress, S. 1040, Reported in Senate 10 Apr. 2025.
Bluebook
S.1040 - 119th Congress (2025-2026): Drug Competition Enhancement Act, S.1040, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119s1040rs.
